Galectin Therapeutics Inc (NASDAQ:GALT)

2.67
Delayed Data
As of Oct 20
 -0.05 / -1.83%
Today’s Change
1.50
Today|||52-Week Range
4.50
-6.64%
Year-to-Date
New Strong Sell Stocks for October 12th
Oct 12 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close2.73
Today’s open2.76
Day’s range2.65 - 2.78
Volume184,417
Average volume (3 months)270,722
Market cap$159.2M
Data as of 3:58pm ET, 10/20/2020

Growth & Valuation

Earnings growth (last year)+32.03%
Earnings growth (this year)+7.69%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.66

Competitors

 Today’s
change
Today’s
% change
BMRABiomerica Inc-0.04-0.71%
TRIBTrinity Biotech PLC-0.29-9.93%
----
IDXGInterpace Bioscience...-0.64-16.04%
Data as of 5:06pm ET, 10/20/2020

Financials

Next reporting dateNovember 10, 2020
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$0.00
Annual profit (last year)-$13.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Norcross, Georgia

Forecasts